RHOA and melanoma: The observed membrane-expressed CD70 down-regulations induced by siRhoA2 transfection or U0126 treatment were not increased by the combination of both treatments (Fig 4E), indicating that RhoA and MAPK pathway have no additive effects on the regulation of melanoma-expressed CD70.